Impact of AIT on Allergic Rhinitis and Asthma

Efficacy and Safety of Sublingual Immunotherapy (SLIT)

NCT01012882 ·Status: UNKNOWN ·Phase: PHASE3

Comparison of Innate Immune Responses Induced by Allergy Immunotherapy (AIT) With Different Adjuvants

NCT04104828 ·Status: COMPLETED

Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy

NCT05448066 ·Status: RECRUITING ·Phase: NA

A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet

NCT01454544 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

NCT00263549 ·Status: COMPLETED ·Phase: PHASE4

A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet

NCT01675791 ·Status: COMPLETED ·Phase: PHASE2

House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma

NCT01433523 ·Status: COMPLETED ·Phase: PHASE3

e-ITAG Allergen Immunotherapy in the Management of Allergic Asthma

NCT06021912 ·Status: UNKNOWN

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

NCT01115595 ·Status: COMPLETED ·Phase: PHASE4

Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy

NCT01720251 ·Status: COMPLETED ·Phase: PHASE2

Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma

NCT05476484 ·Status: UNKNOWN

Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic Rhinitis

NCT03649139 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study

NCT06778213 ·Status: RECRUITING ·Phase: PHASE4

N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France

NCT03746860 ·Status: COMPLETED

Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen

NCT01889875 ·Status: COMPLETED ·Phase: NA

Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.

NCT01795846 ·Status: UNKNOWN

Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment

NCT02143583 ·Status: COMPLETED

Mechanisms of Allergen Immunotherapy

NCT00001910 ·Status: COMPLETED

Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

NCT00857779 ·Status: COMPLETED ·Phase: PHASE2

A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment

NCT05560698 ·Status: COMPLETED ·Phase: NA

Vestibular Versus Sublingual Route of AIT Tablets

NCT05119751 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy

NCT01014325 ·Status: UNKNOWN ·Phase: PHASE3

A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma

NCT02596321 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts

NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3

The Efficacy & Safety of the UAS Immunotherapy Protocol

NCT01699659 ·Status: COMPLETED